Literature DB >> 31499064

Activation of endothelial ras-related C3 botulinum toxin substrate 1 (Rac1) improves post-stroke recovery and angiogenesis via activating Pak1 in mice.

Fan Bu1, Jia-Wei Min1, Yashasvee Munshi1, Yun-Ju Lai1, Li Qi1, Akihiko Urayama1, Louise D McCullough1, Jun Li2.   

Abstract

BACKGROUND AND
PURPOSE: Long-term disability after stroke is common yet the mechanisms of post-stroke recovery are far from clear. It has been suggested that Ras-related C3 botulinum toxin substrate 1 (Rac1) contributes to functional recovery after ischemic stroke in mice. As Rac1 activation plays diverse roles in multiple cell types after central nervous system (CNS) injury, we herein examined the functional role of endothelial Rac1 in post-stroke recovery and angiogenesis.
METHODS: Transient middle cerebral artery occlusion (MCAO) in mice and oxygen-glucose deprivation (OGD) in human brain endothelial cell line-5i (HEBC 5i) were performed to mimic ischemic stroke. Lentivirus vectors encoding Rac1 with GFP and endothelial promotor ENG were injected into the animal's brain after stroke to overexpress Rac1. After injection, stroke recovery was tested by multiple behavioral tests including novel object recognition, adhesive removal and single pellet reaching tests. Endothelial regeneration in the peri-infarct zone was detected by immunohistochemistry (IHC). In the vitro model, the effect of Rac1 and Pak1 inhibitors to cell proliferation and migration was examined by CCK-8 and wound healing assays after OGD. The cellular protein level of brain-derived neurotrophic factor (BDNF), phosphorylated cAMP response element-binding protein (CREB), extracellular signal-regulated kinase (ERK) 1/2 and mitogen-activated protein kinase kinase (MEK) 1/2 were detected by western blots.
RESULTS: Delayed overexpression of endothelial Rac1 after MCAO improved cognitive and sensorimotor recovery from day 14 to 21 after stroke, increased vascular density and the protein level of pericytes in the peri-infarct zone without altering tissue loss in mice. Consistently, inhibition of Rac1 prevented endothelial proliferation and migration after OGD. Pak1 inhibition exerted a similar effect on endothelial cells. However, co-incubation of Rac1 and Pak1 inhibitors with cells did not lead to additive effects when compared with either inhibitor alone. Moreover, individual inhibition of Rac1 or Pak1 suppressed OGD-induced activation of pro-regenerative molecules, including CREB, MEK1/2 and ERK1/2, as well as the production of BDNF in vitro. The level of these proteins did not further decrease if both Rac1 and Pak1 were simultaneously inhibited.
CONCLUSIONS: We conclude that activation of endothelial Rac1 improves functional recovery and angiogenesis after stroke, and this process is mediated by Pak1 signaling. This study provides novel insight for Rac1 in the mechanism of long-term stroke recovery.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Angiogenesis; Functional recovery; Ischemic stroke; Pak1; Rac1

Mesh:

Substances:

Year:  2019        PMID: 31499064      PMCID: PMC6864282          DOI: 10.1016/j.expneurol.2019.113059

Source DB:  PubMed          Journal:  Exp Neurol        ISSN: 0014-4886            Impact factor:   5.330


  52 in total

1.  Specificity and mechanism of action of EHT 1864, a novel small molecule inhibitor of Rac family small GTPases.

Authors:  Adam Shutes; Cercina Onesto; Virginie Picard; Bertrand Leblond; Fabien Schweighoffer; Channing J Der
Journal:  J Biol Chem       Date:  2007-10-11       Impact factor: 5.157

Review 2.  Vascular remodeling after ischemic stroke: mechanisms and therapeutic potentials.

Authors:  Jialing Liu; Yongting Wang; Yosuke Akamatsu; Chih Cheng Lee; R Anne Stetler; Michael T Lawton; Guo-Yuan Yang
Journal:  Prog Neurobiol       Date:  2013-11-27       Impact factor: 11.685

3.  Anticancer efficacy of simvastatin on prostate cancer cells and tumor xenografts is associated with inhibition of Akt and reduced prostate-specific antigen expression.

Authors:  Samith T Kochuparambil; Belal Al-Husein; Anna Goc; Sahar Soliman; Payaningal R Somanath
Journal:  J Pharmacol Exp Ther       Date:  2010-11-08       Impact factor: 4.030

4.  Combined ampakine and BDNF treatments enhance poststroke functional recovery in aged mice via AKT-CREB signaling.

Authors:  Andrew N Clarkson; Kim Parker; Michael Nilsson; F Rohan Walker; Emma K Gowing
Journal:  J Cereb Blood Flow Metab       Date:  2015-03-11       Impact factor: 6.200

5.  Delayed Docosahexaenoic Acid Treatment Combined with Dietary Supplementation of Omega-3 Fatty Acids Promotes Long-Term Neurovascular Restoration After Ischemic Stroke.

Authors:  Hongjian Pu; Xiaoyan Jiang; Xiaoming Hu; Jinchao Xia; Dandan Hong; Wenting Zhang; Yanqin Gao; Jun Chen; Yejie Shi
Journal:  Transl Stroke Res       Date:  2016-08-27       Impact factor: 6.829

Review 6.  The vascular neural network--a new paradigm in stroke pathophysiology.

Authors:  John H Zhang; Jerome Badaut; Jiping Tang; Andre Obenaus; Richard Hartman; William J Pearce
Journal:  Nat Rev Neurol       Date:  2012-10-16       Impact factor: 42.937

7.  Regulation of endothelial nitric oxide synthase and postnatal angiogenesis by Rac1.

Authors:  Naoki Sawada; Salvatore Salomone; Hyung-Hwan Kim; David J Kwiatkowski; James K Liao
Journal:  Circ Res       Date:  2008-07-03       Impact factor: 17.367

Review 8.  Mechanisms and targets for angiogenic therapy after stroke.

Authors:  Deepti Navaratna; Shuzhen Guo; Ken Arai; Eng H Lo
Journal:  Cell Adh Migr       Date:  2009-04-13       Impact factor: 3.405

9.  The adhesive removal test: a sensitive method to assess sensorimotor deficits in mice.

Authors:  Valentine Bouet; Michel Boulouard; Jérôme Toutain; Didier Divoux; Myriam Bernaudin; Pascale Schumann-Bard; Thomas Freret
Journal:  Nat Protoc       Date:  2009-10-01       Impact factor: 13.491

10.  Ras-Related C3 Botulinum Toxin Substrate 1 Promotes Axonal Regeneration after Stroke in Mice.

Authors:  Lin Liu; Hui Yuan; Yanhua Yi; Edward C Koellhoffer; Yashasvee Munshi; Fan Bu; Yi Zhang; Zhenggang Zhang; Louise D McCullough; Jun Li
Journal:  Transl Stroke Res       Date:  2018-02-24       Impact factor: 6.829

View more
  6 in total

Review 1.  RAC1 Activation as a Potential Therapeutic Option in Metastatic Cutaneous Melanoma.

Authors:  Paula Colón-Bolea; Rocío García-Gómez; Berta Casar
Journal:  Biomolecules       Date:  2021-10-20

Review 2.  Rac1, A Potential Target for Tumor Therapy.

Authors:  Jiaxin Liang; Linda Oyang; Shan Rao; Yaqian Han; Xia Luo; Pin Yi; Jinguan Lin; Longzheng Xia; Jiaqi Hu; Shiming Tan; Lu Tang; Qing Pan; Yanyan Tang; Yujuan Zhou; Qianjin Liao
Journal:  Front Oncol       Date:  2021-05-17       Impact factor: 6.244

3.  Activation of neuronal Ras-related C3 botulinum toxin substrate 1 (Rac1) improves post-stroke recovery and axonal plasticity in mice.

Authors:  Fan Bu; Yashasvee Munshi; J Weldon Furr; Jia-Wei Min; Li Qi; Anthony Patrizz; Zachary R Spahr; Akihiko Urayama; Julia K Kofler; Louise D McCullough; Jun Li
Journal:  J Neurochem       Date:  2020-10-06       Impact factor: 5.546

4.  CSRP2 suppresses colorectal cancer progression via p130Cas/Rac1 axis-meditated ERK, PAK, and HIPPO signaling pathways.

Authors:  Lixia Chen; Xiaoli Long; Shiyu Duan; Xunhua Liu; Jianxiong Chen; Jiawen Lan; Xuming Liu; Wenqing Huang; Jian Geng; Jun Zhou
Journal:  Theranostics       Date:  2020-09-02       Impact factor: 11.556

5.  Ganoderic Acid A Promotes Amyloid-β Clearance (In Vitro) and Ameliorates Cognitive Deficiency in Alzheimer's Disease (Mouse Model) through Autophagy Induced by Activating Axl.

Authors:  Li-Feng-Rong Qi; Shuai Liu; Yu-Ci Liu; Ping Li; Xiaojun Xu
Journal:  Int J Mol Sci       Date:  2021-05-24       Impact factor: 5.923

6.  The Cerebroprotein Hydrolysate-I Plays a Neuroprotective Effect on Cerebral Ischemic Stroke by Inhibiting MEK/ERK1/2 Signaling Pathway in Rats.

Authors:  Yuqian Ren; Xiaoqing Ma; Tingting Wang; Baohe Cheng; Leiming Ren; Zehua Dong; Hongling Liu
Journal:  Neuropsychiatr Dis Treat       Date:  2021-07-06       Impact factor: 2.570

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.